Jun. 13 at 7:22 PM
$HCA is trading at a valuation that ignores its status as one of the most efficient compounders in the healthcare sector. Even with the guidance reset and labor cost noise, the massive
$10B buyback authorization proves management isn't worried about the long-term cash flow. Institutions are rotating back into defensive value plays—this is a setup for the patient.
🐂 Bull Level: Reclaim
$415.00 to confirm the move back toward recent highs.
🐻 Bear Level:
$350.00 is the non-negotiable floor; a breakdown here shifts the trend.
#HCA #HCAHealthcare #ValueInvesting #Healthcare #hovdid
